
Keywords: اثربخشی هزینه; MNP; microneedle patch; QALY; quality-adjusted life years; ICER; incremental cost-effectiveness ratio; SEIR; susceptible-exposed-infectious-recovered; BTC; behind-the-counter; WTP; willingness-to-pay; Microneedle patch; Influenza; Influenza vaccination; E